Genetic test for lung spread risk in breast cancer
Part of Cancer, Lungs & breathing clinical trials.
This study looks at how your genes might affect the chance of breast cancer spreading to the lungs and how the disease progresses. The goal is to see if a simple genetic test can help predict these risks, which might guide future treatment decisions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman between 18 and 70 years old.
- You have been diagnosed with breast cancer that has not spread to other parts of the body.
- You have not received any prior treatment for this breast cancer.
- You are generally in good health (able to walk and care for yourself), with normal heart, liver, and kidney function.
- Your blood counts (white blood cells, platelets, and red blood cells) are within a healthy range.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at genetic changes in people with suspected or high-risk lung cancer. It aims to use those results to guide more personalized treatment decisions.
This trial studies if a blood test that looks for tumor DNA combined with a PET-CT scan can better predict if lung cancer has spread to lymph nodes. It may help guide treatment decisions for people with non-small cell lung cancer that hasn't been treated yet.
This trial uses advanced gene sequencing technology on blood and tumor tissue samples from people with non-small cell lung cancer. The goal is to see if this testing can help doctors better predict which treatments will work and detect if the cancer comes back early.
This study collects and analyzes lung cancer tissue samples to understand genetic differences that may help guide future treatment. You'll provide a tissue sample (either from a biopsy or prior surgery), and researchers will study it—no treatment is given in this study.
This trial collects tissue samples from your lung tumor and any tumors that have spread to other parts of your body. They will study the genetic makeup of these samples to better understand lung cancer and improve future treatments.
This study looks at inherited genetic changes in people with a type of lung cancer called lung adenocarcinoma. The goal is to find gene variants linked to the disease, which may help guide future treatment decisions.
Hear when a new Breast Cancer Lung Metastasis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.